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Previewsof the complex. While themutant-induced
differentiation block observed by Mazum-
dar and colleagues is dependent upon
GATA2 and other transcription factors, it
is unclear why GATA binding sites in
particular retain both accessibility and
transcription factor occupancy. One sug-
gestion is that transcription factors like
GATA2 exhibit pioneer activity (i.e., they
can directly bind condensed chromatin)
and may be less dependent on cohesin
than other transcription factors for stable
interaction with chromatin. However, an
alternative possibility may be that the
observed accessibility of GATA binding
sites is a consequence of the differentia-
tion block rather than a driver of it, and
that normal cohesin levels may be
required for the proper promoter-
enhancer interactions required for termi-
nal myeloid differentiation. It seems likely644 Cell Stem Cell 17, December 3, 2015 ª2that more remains to be learned about
the cellular mechanisms by which the
various cohesin mutants contribute to
the pathogenesis of human myeloid
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The identification of tumor-initiating cells represents a significant challenge for studies of prostate cancer. In
a recent issue of Cell Reports, Agarwal and colleagues use organoid culture to ascertain two distinct luminal
progenitors in a mouse model of prostate cancer, shedding new light on lineage relationships in the prostate
epithelium.Despite the clinical significance of pros-
tate cancer, several of the existing
experimental systems used to investigate
its properties have significant limitations.
Notably, few human prostate cancer cell
lines are available for analysis, these
lines are not representative of most
stages of the disease, and establishing
patient-derived xenografts remains
challenging.
In part, these difficulties are associated
with specific properties of epithelial cells
in the normal and transformed prostate
(reviewed in Wang and Shen, 2011). In
the normal prostate epithelium, there arethree primary cell types, corresponding to
the luminal secretory cells, the underlying
basal support cells, and rare neuroendo-
crine cells. In contrast, prostate adenocar-
cinomas,which represent the vastmajority
of prostate tumors, are composed of cells
with a luminal phenotype and are largely
devoid of basal cells. However, prostate
luminal cells are extremely sensitive to
tissue dissociation, after which they fail to
survive in explant culture or grafts, likely
explaining the difficulty in establishing cell
lines aswell as patient-derived xenografts.
As a consequence, there has been an
important gap in our understanding ofthe properties of prostate luminal epithe-
lial cells. Luminal cells have been tradi-
tionally regarded as terminally differenti-
ated and thus unlikely to possess stem/
progenitor activity. On the other hand,
the basal compartment has been consid-
ered a source of stem cells. In the
context of cancer, studies using geneti-
cally engineered mice have identified
tumor-initiating cells in a Pten mutant
model of prostate cancer (Mulholland
et al., 2009), but luminal tumor-initiating
cells have not been identified to date in
either mouse models or human primary
tumors.
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Figure 1. Multipotent and Committed Luminal Progenitors in a Genetically Engineered
Mouse Model of Prostate Cancer
Shown are schematic representations of the two distinct types of organoid morphologies that can arise
from explanted luminal tumor cells and their different properties following serial passaging in culture and
subcutaneous grafting in vivo.
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PreviewsRecent advances in 3D organoid cul-
ture have developed conditions in which
prostate luminal epithelial cells can sur-
vive and proliferate. Notably, many of
the organoids derived from mouse or hu-
man prostate luminal cells are able to
generate basal cells in culture and thus
are multipotent (Chua et al., 2014; Kar-
thaus et al., 2014). As a consequence,
organoid culture provides a new experi-
mental system in which to investigate
the properties of luminal cells from
the wild-type and transformed prostate
epithelium.
In the current study, Agarwal and col-
leagues used organoid culture to investi-
gate the properties of progenitor cells
isolated from a highly aggressive geneti-
cally engineeredmousemodel of prostate
cancer (Agarwal et al., 2015). In this Pten;
Trp53 model, the Pten and p53 tumor
suppressors are conditionally deleted
in the prostate epithelium, resulting in
aggressive adenocarcinomas that often
contain heterogeneous adenosquamous
and sarcomatoid phenotypes at later
stages. Using flow cytometry, the authors
isolated CD49fhi basal cells and PROM1+
luminal cells from Pten; Trp53 prostate tu-
mors as well as phenotypically wild-type
prostate tissue. These explanted cell pop-
ulations were then placed into 3D culture
using previously described media condi-
tions (Karthaus et al., 2014), resulting in
organoid formation from both the basaland luminal populations of Pten; Trp53
prostate tumors.
Basal-derived organoids from wild-
type mice generated organoids with
mixed basal and luminal cells indicative
of multi-lineage differentiation, consistent
with previous findings (Karthaus et al.,
2014). Unlike wild-type basal-derived or-
ganoids, however, basal-derived organo-
ids from Pten; Trp53 tumors lacked any
evidence of multi-lineage differentiation,
suggesting that these organoids corre-
spond to a committed basal cell popula-
tion (Agarwal et al., 2015). Consistent
with this interpretation, the basal-derived
tumor organoids were unable to grow in
subcutaneous grafts.
Interestingly, luminal-derived organoids
from wild-type mouse prostate contained
two different populations (Figure 1). One
populationofwild-type luminal-derivedor-
ganoids displayed multi-lineage differenti-
ation, as previously observed (Chua et al.,
2014; Karthaus et al., 2014). However, a
second luminal-derived organoid popula-
tion corresponded to smaller single-layer
organoids that only contained luminal cells
(Agarwal et al., 2015). Unlike themulti-line-
age organoids, these luminal organoids
were not observed following serial
passaging, suggesting that they possess
limited self-renewal properties and corre-
spond to a committed luminal phenotype.
Consistent with these findings, another
recent study has identified a luminal pro-Cell Stem Cell 17,genitor marked by Sca-1 expression that
can propagate multi-lineage organoids in
culture (Kwon et al., 2015).
Agarwal and colleagues found that
luminal-derived organoids from Pten;
Trp53 tumors also displayed two classes
of morphologies, consistent with their
origin from distinct multipotent and
committed luminal progenitors (Agarwal
et al., 2015). Unlike wild-type committed
luminal organoids, the committed luminal
organoids from Pten; Trp53 tumors could
be propagated through numerous serial
passages. Importantly, the distinction be-
tween multi-lineage and committed
luminal organoids persisted in subcutane-
ous grafts of these organoids.
Similar results were observed using
tumor cells directly isolated from Pten;
Trp53 prostates and injected subcutane-
ously into immunodeficient mice (Agarwal
et al., 2015). Luminal tumor-initiating
cells were relatively rare and gave rise
to two distinct graft phenotypes, corre-
sponding to adenosquamous tumors and
adenocarcinoma with variable sarcoma-
toidmorphology; upon serial engraftment,
the adenosquamous tumors could give
rise to adenocarcinoma phenotypes.
Interestingly, tumor-initiating cells were
also observed in the basal tumor cell
population at a similar frequency and
gave rise to both adenosquamous and
adenocarcinoma phenotypes, despite
the inability of basal tumor cells to
generate multi-lineage organoids in cul-
ture. Notably, these findings indicate that
two classes of luminal progenitors can be
identified in the absence of manipulation
in organoid culture. Furthermore, there
are interesting similarities and differences
with previous work that analyzed human
tumor-propagating cells in xenografts
and identified basal multipotent and
luminal unipotent progenitors (Stoyanova
et al., 2013), whereas the present study
observed both basal and luminal multipo-
tent progenitors.
The current findings raise the central
questionofwhether themultipotent luminal
progenitors observed in organoid culture
also exist in vivo. In particular, lineage-
tracing studies using cytokeratin Cre-
drivers to mark the bulk population of
luminal cells in the normal prostate have
found that the luminal compartment is
self-sustained by unipotent progenitors
(Choi et al., 2012). Raremultipotent luminal
stem cells in the androgen-deprivedDecember 3, 2015 ª2015 Elsevier Inc. 645
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Previewsprostate epithelium (CARNs) have been
analyzed in the context of tissue regen-
eration in vivo (Wang et al., 2009), but
similar cells have not yet been identi-
fied in the hormonally intact prostate
epithelium. Thus, there are at least
three possible explanations that can
reconcile the current findings with pub-
lished lineage-tracing analyses. First, it
is conceivable that lineage-tracing using
cytokeratin drivers may not be suffi-
ciently sensitive to mark rare multipo-
tent progenitors that exist in vivo or
may be somehow biased against their
detection. Second, it is possible that
multipotent luminal progenitors corre-
spond to facultative progenitors that
acquire multipotency in vivo in the
context of tissue repair, as has been
suggested for CARNs during prostate
regeneration (Wang et al., 2009).
Finally, it is conceivable that luminal
cells are not multipotent in vivo, but
instead can display considerable line-
age plasticity and ability to differentiate
into basal cells after removal from their
native tissue microenvironment; a
similar model has been proposed to646 Cell Stem Cell 17, December 3, 2015 ª2explain basal-to-luminal differentiation
that can be readily detected in ex vivo
assays of prostate basal cells (Wang
et al., 2013). In this latter scenario,
oncogenic transformation may enhance
lineage plasticity, as may be the case
for Pten inactivation in promoting
basal-to-luminal differentiation (Wang
et al., 2013).
Given the luminal phenotype of pros-
tate cancer, it is attractive to speculate
that the difficulties in identifying prostate
tumor-initiating cells in patient tumors
may be due to their luminal phenotype
and consequent inability to survive
ex vivo. Thus, the current findings raise
the possibility that organoid culture ap-
proaches may be successful for analysis
of similar cells from human prostate tu-
mors and may lead to future insights into
the initiation and propagation of prostate
cancer.
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